Table 2.
Two Year Postoperative Complication Rate by Procedure Type
| Complication | Total n=587 |
PTRAM n=78 |
FTRAM n=92 |
DIEP n=355 |
SIEA n=62 |
|---|---|---|---|---|---|
| Donor site complication | |||||
| Any donor site complication | 160 (27.3%) | 14 (18%) | 14 (15.2%) | 99 (27.9%) | 33 (53.2%) |
| Hematoma | 12 (2%) | 0 (0%) | 0 (0%) | 8 (2.3%) | 4 (6.5%) |
| Wound dehiscence | 59 (10.1%) | 2 (2.6%) | 3 (3.3%) | 37 (10.4%) | 17 (27.4%) |
| Wound infection | 28 (4.8%) | 6 (7.7%) | 3 (3.3%) | 10 (2.8%) | 9 (14.5%) |
| Donor site necrosis | 34 (5.8%) | 2 (2.6%) | 2 (2.2%) | 25 (7%) | 5 (8.1%) |
| Chronic fat necrosis | 16 (2.7%) | 1 (1.3%) | 1 (1.1%) | 12 (3.4%) | 2 (3.2%) |
| Seroma | 49 (8.3%) | 2 (2.6%) | 3 (3.3%) | 25 (7%) | 19 (30.7%) |
| Abdominal wall bulge, laxity or hernia | 18 (3.1%) | 7 (9%) | 5 (5.4%) | 6 (1.7%) | 0 (0%) |
| Hypertrophic or keloid scarring | 7 (1.2%) | 1 (1.3%) | 1 (1.1%) | 5 (1.4%) | 0 (0%) |
| Breast complication | |||||
| Any breast complication | 174 (29.6%) | 25 (32.1%) | 18 (19.6%) | 110 (31%) | 21 (33.9%) |
| Hematoma | 40 (6.8%) | 3 (3.9%) | 5 (5.4%) | 25 (7%) | 7 (11.3%) |
| Wound dehiscence | 32 (5.5%) | 2 (2.6%) | 3 (3.3%) | 23 (6.5%) | 4 (6.5%) |
| Wound infection | 34 (5.8%) | 7 (9%) | 4 (4.4%) | 22 (6.2%) | 1 (1.6%) |
| Mastectomy skin flap necrosis | 49 (8.3%) | 6 (7.7%) | 6 (6.5%) | 31 (8.7%) | 6 (9.7%) |
| Partial flap necrosis | 20 (3.4%) | 9 (11.5%) | 3 (3.3%) | 8 (2.3%) | 0 (0%) |
| Total flap loss | 7 (1.2%) | 1 (1.3%) | 2 (2.2%) | 4 (1.1%) | 0 (0%) |
| Chronic fat necrosis | 55 (9.4%) | 8 (10.3%) | 6 (6.5%) | 34 (9.6%) | 7 (11.3%) |
| Hypertrophic or keloid scarring | 9 (1.5%) | 0 (0%) | 0 (0%) | 8 (2.3%) | 1 (1.6%) |
| Seroma | 7 (1.2%) | 2 (2.6%) | 0 (0%) | 4 (1.1%) | 1 (1.6%) |